(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VIROQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VIROQ

ST13

US500000079316664

Class

1, 5

Filing

79316664

Registration

7038988

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

06/13/2025

Trademark type

Word

Nice classes

1, 5

Filing date

02/04/2021

Registration date

05/02/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/02/2023

Last transaction

06/13/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

DE

Examiner

GORAN, BRADLEY

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BAG Diagnostics GmbH

Representatives

Andrew Dorisio Dickinson Wright PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals used in industryscience and photography; chemicals used in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides; unprocessed artificial resinsunprocessed plastics; compositions for fire extinguishing and prevention; tempering and soldering preparations; adhesives for use in industry; compostmanuresfertilizers; biological preparations for use in industry and science; biological tissueblood serums for use in scientific and medical research; enzymes for industrial use; primers for diagnostic of viral and bacterial diseases for scientific and research use; nucleotides for scientific and research use; reagents for scientific or medical research useenzyme immunoassays for detecting relevant microorganismstoxinsGMO (genetically modified organisms) and allergens in foodstuffs; products for sterilisation and disinfection controlreagents for testing the sterility of medical equipment; diagnostic preparations for medical and scientific use; chemical test kits for molecular biological deficiencies for laboratory or research use; products for conducting molecular genetic servicesgenetic identity tests comprised of reagents for non-medical purposes

Class 5

Pharmaceuticalsmedical and veterinary preparations for the diagnosis of viral and bacterial diseases; dietetic food and beverages adapted for medical or veterinary usefood for babies; dietary supplements for human beings and animals; plasters and gauze specifically adapted for use for medical dressings; material for stopping teethdental wax; herbicides; vermin destroying preparations; enzymes for medical purposes; primers for the diagnosis of viral and bacterial diseases for medical purposes; medicated preparations in the nature of nucleotides used for diagnostic of viral and bacterial diseases; medical diagnostic test media in liquid and powder form featuring immunofluorescence tests for detecting antibodies; medical diagnostic test media in liquid and powder form for measuring human proteinsmedicated anti-serums for identifying human proteins for the diagnosis of viral and bacterial diseases; diagnostic kits comprised of medical diagnostic reagents and assays for quick testing of bodily fluids and proteins for use in detection of viral and bacterial diseases; diagnostic agentspreparations and substances for medical purposes; genetic identity molecular biological tests comprised of reagents for medical purposes; products for conducting molecular genetic proceduresreagents for use in medical genetic testing

Publications

History of USPTO decisions and trademark events.

41 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/12/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/27/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/07/2023

FIMP

FINAL DISPOSITION PROCESSED

08/07/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/02/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/02/2023

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

03/23/2023

CHPB

POST PUBLICATION AMENDMENT - ENTERED

01/26/2023

APET

ASSIGNED TO PETITION STAFF

01/24/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/23/2023

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

01/09/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/04/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

01/04/2023

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

10/11/2022

GPNX

NOTIFICATION PROCESSED BY IB

10/10/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/13/2022

PUBO

PUBLISHED FOR OPPOSITION

09/13/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/07/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/07/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/24/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/15/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/15/2022

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

07/15/2022

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

04/21/2022

GNFR

FINAL REFUSAL E-MAILED

04/21/2022

CNFR

FINAL REFUSAL WRITTEN

04/21/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/02/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/01/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/01/2022

RFNT

REFUSAL PROCESSED BY IB

10/25/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/02/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/09/2021

RFRR

REFUSAL PROCESSED BY MPU

09/09/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/28/2021

CNRT

NON-FINAL ACTION WRITTEN

08/27/2021

DOCK

ASSIGNED TO EXAMINER

08/27/2021

MAFR

APPLICATION FILING RECEIPT MAILED

08/06/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/02/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/29/2021

Continuous trademark protection

Get notified about every new filing that threatens VIROQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.